Single-Use Pump Market is expected to Grow with a CAGR of 12.99% through 2030
The Single-Use Pump Market is
driven by increasing adoption in biopharmaceutical manufacturing, demand for
contamination-free processes, growing production of biologics, and rising
preference for flexible, cost-effective, and scalable fluid handling solutions.
According to TechSci Research
report, “Single-Use Pump Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Single-Use Pump Market was valued at USD 1.27 Billion in 2024 and is expected to reach USD 2.67 Billion by 2030 with a CAGR of 12.99%. The Single-Use Pump Market is experiencing
significant growth, driven primarily by the increasing adoption of single-use
technologies (SUTs) in the biopharmaceutical and life sciences industries,
where they are revolutionizing the manufacturing of biologics, vaccines, and
cell and gene therapies. Single-use pumps offer enhanced operational
flexibility, reduced contamination risk, and faster turnaround times, which are
critical in the production of high-value, sensitive biological products.
As pharmaceutical companies
continue to shift from traditional stainless-steel systems to disposable
platforms, the demand for pumps that can seamlessly integrate into these
modular systems has surged. Additionally, the growing focus on personalized
medicine and the rise of small-batch production requires pumps that can operate
reliably at varying volumes without extensive cleaning or validation, making
single-use pumps an attractive solution. Another key factor driving market
expansion is the biological market boom, fueled by the increasing prevalence of
chronic diseases, rising investments in research and development, and the
ongoing need for innovative therapeutics.
The scalability of single-use
systems also allows manufacturers to expand production capacity quickly and
cost-effectively, addressing both commercial and clinical production demands.
Moreover, the implementation of strict regulatory standards regarding contamination
control and process validation has prompted manufacturers to adopt single-use
pumps, which minimize cross-contamination risks and simplify compliance
processes. Technological advancements have further strengthened market growth,
as modern single-use pumps now offer improved precision, energy efficiency, and
compatibility with a wide range of bioprocess fluids, including shear-sensitive
and viscous media.
The increasing collaboration
between pump manufacturers and pharmaceutical companies to co-develop
specialized solutions tailored for specific processes also supports market
momentum. Beyond biopharma, rising applications in food and beverage, chemical,
and cosmetics industries are contributing to demand, as these sectors seek
hygienic, low-maintenance pumping solutions capable of handling diverse fluid
types. Cost-effectiveness, combined with the reduced need for cleaning,
sterilization, and downtime, further positions single-use pumps as an
attractive alternative to conventional pumping systems.
Browse over XX Market data
Figures spread through XX Pages and an in-depth TOC on the "Global Single-Use Pump Market.”
Based on the Sterilization, Gamma
Irradiation segment held the largest Market share in 2024. The Gamma
Irradiation segment is a key driver for the global Single-Use Pump Market,
primarily due to its critical role in ensuring sterility and safety in
biopharmaceutical, medical, and life sciences applications. Gamma irradiation
provides an effective and reliable method of sterilizing single-use systems,
including pumps, tubing, and connectors, without compromising their integrity
or functionality, which is essential for maintaining aseptic conditions during
production processes.
As regulatory authorities
worldwide continue to enforce stringent guidelines for contamination control in
the manufacture of biologics, vaccines, and other sensitive therapeutics, the
demand for gamma-irradiated single-use pumps has grown significantly. These
pumps allow manufacturers to reduce the risk of cross-contamination, streamline
production processes, and achieve faster batch turnaround times, supporting the
increasing emphasis on efficiency and safety in drug development and
production. Moreover, the flexibility and disposability of gamma-irradiated
single-use pumps reduce the need for complex cleaning and sterilization
procedures, thereby lowering operational costs and minimizing downtime, which
is particularly attractive to contract manufacturing organizations and
large-scale biopharmaceutical producers.
The ongoing expansion of the
biopharmaceutical sector, fueled by rising demand for biologics, cell and gene
therapies, and personalized medicine, further amplifies the adoption of
gamma-irradiated single-use pump systems, as these technologies are critical to
supporting scalable and contamination-free production. In addition,
advancements in gamma irradiation technology have enhanced the reliability,
uniformity, and throughput of sterilization processes, enabling manufacturers
to meet high-volume production needs without compromising quality. The trend
toward modular and flexible manufacturing facilities, combined with growing
investment in contract manufacturing and outsourced bioproduction, has
positioned gamma-irradiated single-use pumps as an essential component for
modern pharmaceutical operations.
Furthermore, the global push
toward rapid vaccine production, accelerated by public health crises and
pandemic preparedness, has highlighted the importance of pre-sterilized,
ready-to-use single-use systems, including pumps, to ensure safe and efficient bioprocessing.
The ability to maintain sterile fluid handling while supporting complex
processes such as filling, mixing, and transfer makes gamma-irradiated pumps a
preferred choice across diverse applications, from upstream cell culture to
downstream purification. Collectively, these factors—including regulatory
compliance, operational efficiency, cost-effectiveness, scalability, and
safety—underscore the growing reliance on gamma-irradiated single-use pumps,
positioning this segment as a prominent driver of market growth, innovation,
and adoption across global biopharmaceutical and life sciences industries.
Based on region, The
Asia-Pacific region is emerging as the fastest-growing market for single-use
pumps, driven by the rapid expansion of the biopharmaceutical and life sciences
industries. Rising production of biologics, vaccines, and cell & gene
therapies, coupled with increasing investments in bioprocessing facilities and
contract manufacturing organizations (CMOs), is fueling demand for scalable and
contamination-free fluid handling solutions. Additionally, governments across
the region are supporting healthcare infrastructure development and advanced
manufacturing technologies, further accelerating adoption. Growing awareness of
continuous manufacturing and single-use technologies among local manufacturers
positions Asia-Pacific as a key growth engine in the global single-use pump
market.
Major companies operating in
the Global Single-Use Pump Market are:
- GE Healthcare Life Sciences
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Pall Corporation (Danaher
company)
- Watson-Marlow Fluid
Technology Group (WMFTG)
- Eppendorf AG
- Cole-Parmer Instrument
Company LLC
- Iveka, Inc.
- Admix Inc.
- Asahi Kasei Corporation
Download Free Sample Report
Customers can also request
10% free customization in this report.
“The Global Single-Use Pump
Market is expected to rise in the upcoming years and register a significant
CAGR during the forecast period. The Single-Use Pump Market is poised for
robust growth, driven by the expanding biopharmaceutical and life sciences
sectors, where efficient, contamination-free fluid handling is critical. Rising
global demand for biologics, vaccines, and cell & gene therapies is
accelerating the adoption of single-use technologies. Concurrently, increased
investments in bioprocessing facilities and contract manufacturing
organizations (CMOs) are creating avenues for scalable and cost-efficient pump
solutions. The ongoing shift toward continuous manufacturing and process
intensification further bolsters market potential. High-growth regions, notably
Asia-Pacific and Latin America, present significant opportunities due to
expanding healthcare infrastructure and rising biologics production,
positioning single-use pumps as strategic enablers in modern biomanufacturing. Therefore,
the Market of Single-Use Pump is expected to boost in the upcoming years.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.
“Single-Use
Pump Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented, By Material (Polypropylene, Polyethylene, Polystyrene,
Polycarbonate), By Application (Liquid Analysis, Environmental Monitoring,
Medical Diagnostics, Pharmaceutical Production), By Sterilization (Gamma
Irradiation, Ethylene Oxide, Steam), By Region, By Competition, 2020-2030F”, has evaluated the future
growth potential of Global Single-Use Pump Market and provides statistics &
information on the Market size, structure, and future Market growth. The report
intends to provide cutting-edge Market intelligence and help decision-makers
make sound investment decisions., The report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
the Global Single-Use Pump Market.
Contact
Techsci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States-
10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com